BRISTOL-MYERS SQUIBB COMPANY CE
CELG-RI 0.87
EPS (as of 2023-12-31)
Use left/right arrow keys to switch.Breakdowns
| Name | Value |
|---|
| Revenues | 11.9B |
| Cost of Revenue | 2.9B |
| Gross Profit | 8.9B |
| Operating Expense | 7.4B |
| Operating I/L | 3.9B |
| Other Income/Expense | -2.9B |
| Interest Income | 0.0B |
| Pretax | -11.5B |
| Income Tax Expense | 0.4B |
| Net Income/Loss | -11.9B |
Bristol-Myers Squibb Company Ce
Trending Profiles
This is the ALPHA version. The tool and data may contain incorrect information. Please read it with caution.
